News

Drug developers aren’t expected to come back to the US equity markets in full force until next year — lagging other ...
Sam Altman, best known as the CEO of OpenAI, has steadily built a large and diverse investment portfolio that spans ...
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Puma Biotech (PBYI) could be a great choice. It is one of the several stocks that ...
"Under Vision 2030, the Kingdom has emerged as a hub to innovate, invest and build the future breakthroughs that will ...
MHRA approves Loba Biotech to manufacture Pegasys API, enabling pharma& to strengthen UK supply and ensure continued access for eligible patients.
LLR Partners has made a growth investment in TruTechnologies, a Research Triangle Park, North Carolina-based provider of real ...
FDA places clinical hold of RP-A501 for the treatment of patients with Danon disease due to a patient death. Click here to ...
Zai Lab accelerates innovative drug launches in China through partnerships and expertise, targeting $1.5-$2B revenue by 2028.
While MIC2025 was officially shelved from public discourse in 2018 due to intense international backlash, its core objectives ...
Celebrating the top Seed stage investors in 2025 who made early bets on the startups driving today’s AI revolution.
HANOI: Deputy Prime Minister Le Thanh Long has approved a national plan to develop high-quality human resources for the ...
A former employee of AmplifyBio is suing the shuttered biotechnology firm, alleging the company laid off its workers without ...